Patent Cooperation Treaty: Amending International Applications, Curing Defects, Rectifying Obvious Mistakes, Errors
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE course will guide patent practitioners through the Patent Cooperation Treaty (PCT) and its amendment process. The panel will discuss amending claims, specifications, and drawings, as well as correcting errors and defects in the application. The panel will also discuss how to use the PCT to obtain international patent protection strategically.
- PCT application process
- Amending claims
- Amending specifications and drawings
- Correcting errors and defects
- Strategically using the PCT to maximize patent protection
The panel will review these and other key issues:
- What are the benefits of and reasons to use the PCT?
- What are the challenges when seeking to amend the claims of the PCT application? The drawings? The specifications?
- What are the limitations when seeking to correct errors, cure defects, or rectify apparent mistakes in the PCT application?
Rebecca M. McNeill
Ms. McNeill offers intellectual property strategy and advises on new application preparation, patent prosecution (U.S.... | Read More
Ms. McNeill offers intellectual property strategy and advises on new application preparation, patent prosecution (U.S. and foreign), and preparation and negotiation of IP transactions, and provides the full scope of counseling services. She has a special interest in counseling clients on patent application filing and developing worldwide prosecution strategies in concert with clients’ business goals. She has managed and directed the U.S. and international patent portfolios for U.S. clients and has overseen the U.S. patent portfolio for international clients in Europe and Asia.Close
Jens Viktor Nørgaard
Partner, Head of Biotechnology & Plant Sciences
Mr. Nørgaard counsels on all areas of life science and medical technology including anything from genetics and... | Read More
Mr. Nørgaard counsels on all areas of life science and medical technology including anything from genetics and molecular biology to drugs, diagnostics, analytical equipment, medical equipment, and greentech. He counsels on IPR strategy, IPR organization and management of companies, business development, license agreements, freedom-to-operate, validity of patents, oppositions and appeals before the EPO (European Patent Office), in addition to drafting and prosecution of patent applications. He also serves as a technical judge in Norway. Since 2015 he has served as Chairman of the Board at HØIBERG.Close